Navigation Links
K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P
Date:10/13/2011

ST. LOUIS, Oct. 13, 2011 /PRNewswire/ -- K-V Pharmaceutical Company (the "Company") (NYSE: KV.A/KV.B) appreciates that the American College of Obstetricians and Gynecologists (ACOG) and Society for Maternal-Fetal Medicine (SMFM) have issued an information update that ensures healthcare providers, patients, and the payer community have the facts regarding FDA-approved Makena™.  The information update emphasizes that previous ACOG and SMFM statements regarding Makena were not intended to be used by private or public payers as a basis for interfering with the medical judgment of healthcare providers or denying patient access to Makena.  It also states that physicians should understand the inherent differences between an FDA-approved manufactured product and a compounded preparation, and that ACOG and SMFM's previous statements were not meant to suggest that Makena and compounded 17P are identical products.  

Healthcare providers understand that evidence-based medicine is the foundation of clinical practice.  Evidence from the NICHD MFMU Network study (Meis, et al.) supporting the use of hydroxyprogesterone caproate (17P) was based on drug manufactured under FDA's Good Manufacturing Practices (GMP) conditions, and not on drug made using compounding processes or obtained from compounding pharmacies.  The drug used in the NICHD study is available today as FDA-approved Makena.  

Access to FDA-approved Makena for clinically-indicated patients is an important public health priority.  Certain payer coverage policies have been influenced by a belief that unapproved compounded 17P formulations are the same as Makena.  These policies should be modified to ensure that clinically-indicated patients have unencumbered access to FDA-approved Makena, consistent with their healthcare provider's medical judgment.  

As part of our commitment to patients, we have made substantial efforts to work with the payer com
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... addition of the "Electro Surgical Market" ... electrosurgical market is expected to achieve a CAGR ... surgery offer huge benefits for patients as well ... surgery infections, condensed visible marks, bleeding control and ...
(Date:5/5/2015)... and ST. LOUIS , May ... pressure or high cholesterol may achieve better health outcomes ... according to early results of a unique program conducted ... ESRX ). "Pharmacists are one of the ... interactions with our members presents enormous opportunities to positively ...
(Date:5/5/2015)... , May 5, 2015 Big Market ... the US, Europe , ( France ... Spain , UK) and Japan ... are reviewed. The report provides the 5-year test volume and sales ... HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ...
Breaking Medicine Technology:Global Electro Surgical Market 2015 2SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 2SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 3SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 42015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3
... Pa., May 31, 2011 Endo Pharmaceuticals (Nasdaq: ... and Alan Levin, executive vice president and chief financial officer ... Conference on Tuesday, June 7, 2011 at 9:00 a.m. ET. ... New York City, NY. A live webcast and ...
... CITY, Calif., May 31, 2011 Abaxis, Inc. (NasdaqGS: ... systems, announced today that Don Wood, chief operations officer, ... Tuesday, June 7, 2011 at 11:30 a.m. ET at ... AbaxisAbaxis develops, manufactures, markets and sells portable blood analysis ...
Cached Medicine Technology:
(Date:5/5/2015)... May 05, 2015 AxoGen, Inc. ... on the $1.6 billion peripheral nerve repair market, reported ... ended March 31, 2015 compared to $3.14 million in ... adoption of our proprietary portfolio of nerve repair products ... AxoGuard® Nerve Protector – and our solid sales execution ...
(Date:5/5/2015)... The global lab automation market is ... Million in 2014, at an estimated CAGR of 6.7% ... automation market on the basis of equipment and software, ... the basis of application, Lab Automation Market is classified ... solutions. Drug discovery is a major application of the ...
(Date:5/5/2015)... TX (PRWEB) May 05, 2015 ... selected C.R. Bard Inc., a leading multinational developer, ... in the fields of vascular, urology, oncology and ... 2015 Vanguard Award. The Vanguard Award recognizes ... employee wellness programs among Viverae’s significant client base. ...
(Date:5/5/2015)... Dr. Patricia George knows all too ... pulmonologist and pulmonary hypertension specialist at the University of ... event when an initial idea entered her mind for ... the audience at the 2010 PHA International Conference,” George ... – were recalling their climb up Mt. Kilimanjaro and ...
(Date:5/5/2015)... 05, 2015 In a April 25, 2015, ... Herald-Times , the Missouri State Highway Patrol (MSHP) announced that ... or use for the second year in a row. ... FBI, reported 1,469 incidents in 2014 alone, around 15% of ... 2% of the US Population calls Indiana home, according to ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2
... analysis by Metropolitan Transportation Authority, Sick subway passengers who ... the top// causes, after the track works and signal ... ,Asim Nelson, a transit emergency medical technician said ... 2005 and October 2006, shows that fainting dieters topped ...
... a worrying development, Jammu and Kashmir has reported its first case ... years even as 14 cases were// detected across India in December-end. ... with the disease touched 624 in 2006 - a very high ... was the first case of polio from Jammu and Kashmir. In ...
... Jan. 5, 2007,that is designed to bring down medication ... help// pharmacists to be more involved in direct ... non-discretionary (clerical) tasks. The new regulation empowers general acute ... technicians to check the work of other technicians, to ...
... certain patients following a liver transplant. A new study on ... the risk factors can be detected before a transplant is ... ,They found the risk factors - a history ... paired with the use of a particular immunosuppressant- increase risk ...
... a warning about an imminent government directive that seeks ... This move is feared to choke on going research ... Fertilization and Embryology Authority in Britain will decide in ... is amid numerous applications from stem cell experts for ...
... The younger someone starts drinking alcoholic beverages, the more ... drink to relieve stress when older, a large new ... drinking among persons who started drinking at 14 or ... of drinking are already higher than those of other ...
Cached Medicine News:Health News:Fresh Polio Case Reported in Jammu 2Health News:New Regulation to Check Medication Errors 2Health News:Risk Factors That Cause NODM After A Liver Transplant 2Health News:Youngest Drinkers Likelier to Use Alcohol for Stress Relief as Adults 2
... The HypercleanTM 2 fume ... for enclosing benchtop equipment. ... fit comfortably inside the Hyperclean ... fume containment system unit comes ...
Reusable shielded cable...
... OIA test features a dual-detection technology to ... for children under age 5 with a ... in just over 15 minutes. This combination ... to decrease costs for unnecessary ancillary testing, ...
... A/B test combines performance equivalence to 14-day viral ... or B with a simple, easy-to-use test with ... has all the same procedural steps as our ... you decrease costs for unnecessary ancillary testing, improve ...
Medicine Products: